Autopsy report · NCT02102438

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

“No financial support aproved”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Instituto do Cancer do Estado de São Paulo

Sponsor type

University, hospital or other

Conditions

Breast Cancer; HER-2 Positive Breast Cancer

Interventions

Trastuzumab; Weekly Paclitaxel; Carboplatin

Participants

0

Sites

1

Countries

Brazil

Trials that died the same way

• Treatment of Covid-19 Infections Using Vitality Therapy or the Bible Cure
  “No Financial Support” (93% match in meaning)
• IntraDermal Versus Intramuscular Comirnaty® Efficacy Study
  “No financial budget support” (81% match in meaning)
• Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor
  “Lack of financial support” (80% match in meaning)
• Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors
  “no funding support” (77% match in meaning)
• FSH Doser for Controlled Ovarian Stimulation
  “Seeking financial support.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.